Elutia Quote - ELUT

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

3.48

Bid

3.48

Ask

3.55

Volume

59,245

3.3601 Day's Range 3.68

1.10 52 Week Range 4.3899

Market Cap

36.167M

Previous Close

3.27

Open

3.67

Last Trade

3.515

Last Trade Time

12:42:42

Financial Volume

US$ 209,398

VWAP

3.5344

Average Volume (3m)

30,699

Shares Outstanding

24,273,427

Dividend Yield

PE Ratio

-0.96

Earnings Per Share (EPS)

-1.55

Revenue

24.75M

Net Profit

-37.66M

Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted ... Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.elutia.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Elutia Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ELUT. The last closing price for Elutia was US$3.27. Over the last year, Elutia shares have traded in a share price range of US$ 1.10 to US$ 4.3899.

Elutia currently has 24,273,427 shares outstanding. The market capitalization of Elutia is US$36.17 million. Elutia has a price to earnings ratio (PE ratio) of -0.96.

Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators

EluPro becomes the only drug-eluting biologic envelope to receive FDA clearance in the $600 million U.S. implantable electronic device protection market EluPro also granted clearance for...

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.37	-9.61038961039	3.85	4.11	3.02	223772	3.24416787	CS
4	0.11	3.26409495549	3.37	4.3899	2.8901	64500	3.32810896	CS
12	0.31	9.77917981073	3.17	4.3899	2.72	30699	3.2554793	CS
26	1.35	63.3802816901	2.13	4.3899	1.86	28118	3.25795477	CS
52	2.29	192.43697479	1.19	4.3899	1.1	166390	1.77373914	CS
156	2.29	192.43697479	1.19	4.3899	1.1	166390	1.77373914	CS
260	2.29	192.43697479	1.19	4.3899	1.1	166390	1.77373914	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GRCGold Springs Resource Corp	$ 0.09 (20.00%)	108.2k
NUMINuminus Wellness Inc	$ 0.06 (20.00%)	1.58M
SFDNXT Energy Solutions Inc	$ 0.16 (18.52%)	118k
SAMStarcore International Mines Ltd	$ 0.14 (16.67%)	525
XLYAuxly Cannabis Group Inc	$ 0.035 (16.67%)	115.8k
LPENLoop Energy Inc	$ 0.025 (-16.67%)	15.04k
CDRCondor Energies Inc	$ 1.51 (-13.22%)	16.98k
ETEvertz Technologies Ltd	$ 13.44 (-12.39%)	84.03k
FTUUS Financial 15 Split Corp	$ 0.325 (-12.16%)	2.5k
AIDXHealWell AI Inc	$ 2.35 (-11.65%)	763.15k
CNQCanadian Natural Resources Ltd	$ 47.92 (1.46%)	7.74M
BITFBitfarms Ltd	$ 4.15 (-2.12%)	5.49M
POWPower Corp of Canada	$ 37.50 (-0.90%)	3.02M
HHydro One Limited	$ 38.47 (-0.59%)	2.94M
ATHAthabasca Oil Corporation	$ 4.93 (-0.40%)	2.83M